Literature DB >> 19147494

KSR1 is required for cell cycle reinitiation following DNA damage.

Gina L Razidlo1, Heidi J Johnson, Scott M Stoeger, Kenneth H Cowan, Tadayoshi Bessho, Robert E Lewis.   

Abstract

KSR1 (kinase suppressor of Ras 1) is a molecular scaffold and positive regulator of the Raf/MEK/ERK phosphorylation cascade. KSR1 is required for maximal ERK activation induced by growth factors and by some cytotoxic agents. We show here that KSR1 is also required for maximal ERK activation induced by UV light, ionizing radiation, or the DNA interstrand cross-linking agent mitomycin C (MMC). We further demonstrate a role for KSR1 in the reinitiation of the cell cycle and proliferation following cell cycle arrest induced by MMC. Cells lacking KSR1 underwent but did not recover from MMC-induced G(2)/M arrest. Expression of KSR1 allowed KSR1(-/-) cells to re-enter the cell cycle following MMC treatment. However, cells expressing a mutated form of KSR1 unable to bind ERK did not recover from MMC-induced cell cycle arrest, demonstrating the requirement for the KSR1-ERK interaction. In addition, constitutive activation of ERK was not sufficient to promote cell cycle reinitiation in MMC-treated KSR1(-/-) cells. Only cells expressing KSR1 recovered from MMC-induced cell cycle arrest. Importantly, MMC-induced DNA damage was repaired in KSR1(-/-) cells, as determined by resolution of gamma-H2AX-containing foci. These data indicate that cell cycle reinitiation is not actively signaled in the absence of KSR1, even when DNA damage has been resolved. These data reveal a specific role for the molecular scaffold KSR1 and KSR1-mediated ERK signaling in the cellular response to DNA interstrand cross-links.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147494      PMCID: PMC2652329          DOI: 10.1074/jbc.M806457200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

Review 1.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.

Authors:  C G Takizawa; D O Morgan
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

2.  Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease.

Authors:  I Kuraoka; W R Kobertz; R R Ariza; M Biggerstaff; J M Essigmann; R D Wood
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

Review 4.  Formation and repair of interstrand cross-links in DNA.

Authors:  David M Noll; Tracey McGregor Mason; Paul S Miller
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

5.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1.

Authors:  Y Zeng; K C Forbes; Z Wu; S Moreno; H Piwnica-Worms; T Enoch
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

6.  Measurement of micronuclei in lymphocytes.

Authors:  M Fenech; A A Morley
Journal:  Mutat Res       Date:  1985 Feb-Apr       Impact factor: 2.433

7.  Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs.

Authors:  S Li; C Y Ku; A A Farmer; Y S Cong; C F Chen; W H Lee
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

8.  The decision to enter mitosis.

Authors:  W G Dunphy
Journal:  Trends Cell Biol       Date:  1994-06       Impact factor: 20.808

Review 9.  Cyclobutane-type pyrimidine dimers in polynucleotides.

Authors:  R B Setlow
Journal:  Science       Date:  1966-07-22       Impact factor: 47.728

10.  Mitomycin C upregulates IL-8 and MCP-1 chemokine expression via mitogen-activated protein kinases in corneal fibroblasts.

Authors:  San-Fang Chou; Shu-Wen Chang; Jia-Ling Chuang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

View more
  6 in total

Review 1.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

Review 2.  KSR as a therapeutic target for Ras-dependent cancers.

Authors:  Beth K Neilsen; Danielle E Frodyma; Robert E Lewis; Kurt W Fisher
Journal:  Expert Opin Ther Targets       Date:  2017-04-07       Impact factor: 6.902

3.  KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.

Authors:  David Llobet; Nuria Eritja; Monica Domingo; Laura Bergada; Cristina Mirantes; Maria Santacana; Judit Pallares; Anna Macià; Andree Yeramian; Mario Encinas; Gema Moreno-Bueno; Jose Palacios; Robert E Lewis; Xavier Matias-Guiu; Xavi Dolcet
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 4.  Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

Authors:  F Wei; J Yan; D Tang
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  Regulation of glucose homeostasis by KSR1 and MARK2.

Authors:  Paula J Klutho; Diane L Costanzo-Garvey; Robert E Lewis
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

Review 6.  Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway.

Authors:  Pui-Kei Wu; Andrew Becker; Jong-In Park
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.